HK1009393A1 - Method for treating cognitive dysfunction - Google Patents

Method for treating cognitive dysfunction

Info

Publication number
HK1009393A1
HK1009393A1 HK98110242A HK98110242A HK1009393A1 HK 1009393 A1 HK1009393 A1 HK 1009393A1 HK 98110242 A HK98110242 A HK 98110242A HK 98110242 A HK98110242 A HK 98110242A HK 1009393 A1 HK1009393 A1 HK 1009393A1
Authority
HK
Hong Kong
Prior art keywords
cognitive dysfunction
treating cognitive
treating
methyl
benzodiazepine
Prior art date
Application number
HK98110242A
Other languages
English (en)
Inventor
Clarles M Beasley Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002219902A external-priority patent/CA2219902A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1009393A1 publication Critical patent/HK1009393A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Processing Of Meat And Fish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
HK98110242A 1995-05-30 1998-08-26 Method for treating cognitive dysfunction HK1009393A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002219902A CA2219902A1 (en) 1995-05-30 1995-05-30 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
PCT/US1995/006859 WO1996038151A1 (en) 1995-05-30 1995-05-30 Method for treating cognitive dysfunction

Publications (1)

Publication Number Publication Date
HK1009393A1 true HK1009393A1 (en) 1999-06-04

Family

ID=25679786

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110242A HK1009393A1 (en) 1995-05-30 1998-08-26 Method for treating cognitive dysfunction

Country Status (17)

Country Link
EP (1) EP0828494B1 (xx)
JP (1) JPH11506096A (xx)
AT (1) ATE220550T1 (xx)
AU (1) AU707858B2 (xx)
CZ (1) CZ292565B6 (xx)
DE (1) DE69527442T2 (xx)
DK (1) DK0828494T3 (xx)
ES (1) ES2180643T3 (xx)
FI (1) FI973987A (xx)
HK (1) HK1009393A1 (xx)
HU (1) HUT77907A (xx)
MX (1) MX9707936A (xx)
NO (1) NO318553B1 (xx)
NZ (1) NZ288037A (xx)
PL (1) PL189714B1 (xx)
PT (1) PT828494E (xx)
WO (1) WO1996038151A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US7932249B2 (en) 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270464A (en) * 1989-03-14 1993-12-14 Janssen Pharmaceutica N.V. Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
AU707858B2 (en) 1999-07-22
DE69527442D1 (de) 2002-08-22
DE69527442T2 (de) 2003-02-20
EP0828494A4 (en) 1999-11-24
MX9707936A (es) 1997-12-31
PL189714B1 (pl) 2005-09-30
HUT77907A (hu) 1998-10-28
EP0828494A1 (en) 1998-03-18
NO318553B1 (no) 2005-04-11
ES2180643T3 (es) 2003-02-16
FI973987A0 (fi) 1997-10-17
WO1996038151A1 (en) 1996-12-05
FI973987A (fi) 1997-10-17
PT828494E (pt) 2002-10-31
NO974766D0 (no) 1997-10-15
AU2693695A (en) 1996-12-18
JPH11506096A (ja) 1999-06-02
NZ288037A (en) 1999-09-29
NO974766L (no) 1997-12-09
DK0828494T3 (da) 2002-09-02
ATE220550T1 (de) 2002-08-15
CZ324397A3 (cs) 1998-08-12
EP0828494B1 (en) 2002-07-17
PL323785A1 (en) 1998-04-27
CZ292565B6 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
MY114701A (en) Process and crystal forms of 2-methyl-thieno- benzodiazepine
IL113912A (en) Use of 2-methyl-10-(4-methyl-1- piperazinyl)-4h-thieno-[2,3-b] [1,5] benzodiazepine for the treatment of functional bowel disorders
NZ510208A (en) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
IL117971A0 (en) Method for treating dyskinesias
HK1009393A1 (en) Method for treating cognitive dysfunction
SI0733634T1 (en) Process for preparing a thieno(2,3-B)(1,5) benzodiazepine derivative
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
EP0911028A3 (en) Method for treating sexual dysfunction
NZ332037A (en) Olanzapine for treating migraine pain
EP0831835A4 (en) METHOD FOR TREATING ANOREXIA
MX9805358A (es) Procedimiento para la aminocarbonilacion de benzazepinas y benzodiazepinas.
ZA976854B (en) Treatment of psychotic disorders.
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
NZ331846A (en) Method for preparing a medicament using olanzapine for treating insomnia
JO1926B1 (en) The process of forming crystalline forms of 2- methyl tinzo benzodiazepine

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060530